Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2015

01-06-2015 | Review

The Effect of Charge Display on Cost of Care and Physician Practice Behaviors: A Systematic Review

Authors: Celine Goetz, MD, Stephen R. Rotman, MD, George Hartoularos, Tara F. Bishop, MD, MPH

Published in: Journal of General Internal Medicine | Issue 6/2015

Login to get access

ABSTRACT

BACKGROUND

While studies have been published in the last 30 years that examine the effect of charge display during physician decision-making, no analysis or synthesis of these studies has been conducted.

OBJECTIVE

We aimed to determine the type and quality of charge display studies that have been published; to synthesize this information in the form of a literature review.

METHODS

English-language articles published between 1982 and 2013 were identified using MEDLINE, Web of Knowledge, ABI-Inform, and Academic Search Premier. Article titles, abstracts, and text were reviewed for relevancy by two authors. Data were then extracted and subsequently synthesized and analyzed.

RESULTS

Seventeen articles were identified that fell into two topic categories: the effect of charge display on radiology and laboratory test ordering versus on medication choice. Seven articles were randomized controlled trials, eight were pre-intervention vs. post-intervention studies, and two interventions had a concurrent control and intervention groups, but were not randomized. Twelve studies were conducted in a clinical environment, whereas five were survey studies. Of the nine clinically based interventions that examined test ordering, seven had statistically significant reductions in cost and/or the number of tests ordered. Two of the three clinical studies looking at medication expenditures found significant reductions in cost. In the survey studies, physicians consistently chose fewer tests or lower cost options in the theoretical scenarios presented.

CONCLUSIONS

In the majority of studies, charge information changed ordering and prescribing behavior.
Literature
1.
go back to reference McCarthy D et al. Why not the best? Results from the National Scorecard on U.S. Health System Performance, 2011. 2011, The Commonwealth Fund Commission on a High Performance Health System. McCarthy D et al. Why not the best? Results from the National Scorecard on U.S. Health System Performance, 2011. 2011, The Commonwealth Fund Commission on a High Performance Health System.
3.
go back to reference Graham JD, Potyk D, Raimi E. Hospitalists’ awareness of patient charges associated with inpatient care. J Hosp Med. 2010;5(5):295–297.CrossRefPubMed Graham JD, Potyk D, Raimi E. Hospitalists’ awareness of patient charges associated with inpatient care. J Hosp Med. 2010;5(5):295–297.CrossRefPubMed
4.
go back to reference Allan GM, Lexchin J. Physician awareness of diagnostic and nondrug therapeutic costs: a systematic review. Int J Technol Assess Health Care. 2008;24(2):158–165.CrossRefPubMed Allan GM, Lexchin J. Physician awareness of diagnostic and nondrug therapeutic costs: a systematic review. Int J Technol Assess Health Care. 2008;24(2):158–165.CrossRefPubMed
5.
go back to reference Kullgren JT, et al. A census of state health care price transparency websites. JAMA. 2003;309(23):2437–2438.CrossRef Kullgren JT, et al. A census of state health care price transparency websites. JAMA. 2003;309(23):2437–2438.CrossRef
6.
go back to reference Sinaiko AD, et al. Increased price transparency in health care—challenges and potential effects. N Engl J Med. 2011;364(10):891–894.CrossRefPubMed Sinaiko AD, et al. Increased price transparency in health care—challenges and potential effects. N Engl J Med. 2011;364(10):891–894.CrossRefPubMed
7.
8.
go back to reference Bernstein JRH, et al. Availability of consumer prices from Philadelphia area hospitals for common services: electrocardiograms vs. parking. JAMA Intern Med. 2014;174(2):292–293.CrossRefPubMed Bernstein JRH, et al. Availability of consumer prices from Philadelphia area hospitals for common services: electrocardiograms vs. parking. JAMA Intern Med. 2014;174(2):292–293.CrossRefPubMed
9.
go back to reference Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, O’Brien MA, Johansen M, Grimshaw J, Oxman AD. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;13:16. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, O’Brien MA, Johansen M, Grimshaw J, Oxman AD. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;13:16.
10.
go back to reference Axt-Adam P, van der Wouden MA, van der Does E. Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care. 1993;31(9):784–794.CrossRefPubMed Axt-Adam P, van der Wouden MA, van der Does E. Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care. 1993;31(9):784–794.CrossRefPubMed
11.
go back to reference Bates DW, et al. Does the computerized display of charges affect inpatient ancillary test utilization? Arch Intern Med. 1997;157(21):2501–2508.CrossRefPubMed Bates DW, et al. Does the computerized display of charges affect inpatient ancillary test utilization? Arch Intern Med. 1997;157(21):2501–2508.CrossRefPubMed
12.
go back to reference Durand DJ, et al. Provider cost transparency alone has no impact on inpatient imaging utilization. J Am Coll Radiol. 2013;10(2):108–113.CrossRefPubMed Durand DJ, et al. Provider cost transparency alone has no impact on inpatient imaging utilization. J Am Coll Radiol. 2013;10(2):108–113.CrossRefPubMed
13.
go back to reference Ellemdin S, Rheeder P, Soma P. Providing clinicians with information on laboratory test costs leads to reduction in hospital expenditure. S Afr Med J. 2011;101(10):746–748.PubMed Ellemdin S, Rheeder P, Soma P. Providing clinicians with information on laboratory test costs leads to reduction in hospital expenditure. S Afr Med J. 2011;101(10):746–748.PubMed
14.
go back to reference Feldman LS, et al. Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med. 2013;173(10):903–908.CrossRefPubMed Feldman LS, et al. Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med. 2013;173(10):903–908.CrossRefPubMed
15.
go back to reference Hampers LC, et al. The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics. 1999;103(4 Pt 2):877–882.PubMed Hampers LC, et al. The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics. 1999;103(4 Pt 2):877–882.PubMed
16.
go back to reference Sachdeva RC, et al. Effects of availability of patient-related charges on practice patterns and cost containment in the pediatric intensive care unit. Crit Care Med. 1996;24(3):501–506.CrossRefPubMed Sachdeva RC, et al. Effects of availability of patient-related charges on practice patterns and cost containment in the pediatric intensive care unit. Crit Care Med. 1996;24(3):501–506.CrossRefPubMed
17.
go back to reference Schilling UM. Cutting costs: the impact of price lists on the cost development at the emergency department. Eur J Emerg Med. 2010;17(6):337–339.CrossRefPubMed Schilling UM. Cutting costs: the impact of price lists on the cost development at the emergency department. Eur J Emerg Med. 2010;17(6):337–339.CrossRefPubMed
18.
go back to reference Seguin P, et al. Effects of price information on test ordering in an intensive care unit. Intensive Care Med. 2002;28(3):332–335.CrossRefPubMed Seguin P, et al. Effects of price information on test ordering in an intensive care unit. Intensive Care Med. 2002;28(3):332–335.CrossRefPubMed
19.
go back to reference Tierney WM, Miller ME, McDonald CJ. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N Engl J Med. 1990;322(21):1499–1504.CrossRefPubMed Tierney WM, Miller ME, McDonald CJ. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N Engl J Med. 1990;322(21):1499–1504.CrossRefPubMed
20.
go back to reference Horrow JC, Rosenberg H. Price stickers do not alter drug usage. Can J Anaesth. 1994;41(11):1047–1052.CrossRefPubMed Horrow JC, Rosenberg H. Price stickers do not alter drug usage. Can J Anaesth. 1994;41(11):1047–1052.CrossRefPubMed
21.
go back to reference Lin YC, Miller SR. The impact of price labeling of muscle relaxants on cost consciousness among anesthesiologists. J Clin Anesth. 1998;10(5):401–403.CrossRefPubMed Lin YC, Miller SR. The impact of price labeling of muscle relaxants on cost consciousness among anesthesiologists. J Clin Anesth. 1998;10(5):401–403.CrossRefPubMed
22.
go back to reference McNitt JD, Bode ET, Nelson RE. Long-term pharmaceutical cost reduction using a data management system. Anesth Analg. 1998;87(4):837–842.PubMed McNitt JD, Bode ET, Nelson RE. Long-term pharmaceutical cost reduction using a data management system. Anesth Analg. 1998;87(4):837–842.PubMed
23.
go back to reference Cummings KM, et al. The effects of price information on physicians’ test-ordering behavior. Ordering of diagnostic tests. Med Care. 1982;20(3):293–301.CrossRefPubMed Cummings KM, et al. The effects of price information on physicians’ test-ordering behavior. Ordering of diagnostic tests. Med Care. 1982;20(3):293–301.CrossRefPubMed
24.
go back to reference Rudy DW, et al. A pilot study assessing the influences of charge data and group process on diagnostic test ordering by residents. Acad Med. 2001;76(6):635–637.CrossRefPubMed Rudy DW, et al. A pilot study assessing the influences of charge data and group process on diagnostic test ordering by residents. Acad Med. 2001;76(6):635–637.CrossRefPubMed
25.
go back to reference Hart J, et al. Do drug costs affect physicians’ prescription decisions? J Intern Med. 1997;241(5):415–420.CrossRefPubMed Hart J, et al. Do drug costs affect physicians’ prescription decisions? J Intern Med. 1997;241(5):415–420.CrossRefPubMed
26.
go back to reference Hux JE, Naylor CD. Drug prices and third party payment: do they influence medication selection? Pharmacoeconomics. 1994;5(4):343–350.CrossRefPubMed Hux JE, Naylor CD. Drug prices and third party payment: do they influence medication selection? Pharmacoeconomics. 1994;5(4):343–350.CrossRefPubMed
27.
go back to reference Salman H, et al. The effect of drug cost on hypertension treatment decision. Publ Health. 1999;133:243–246.CrossRef Salman H, et al. The effect of drug cost on hypertension treatment decision. Publ Health. 1999;133:243–246.CrossRef
28.
29.
go back to reference May TA, et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol. 2006;126(2):200–206.CrossRefPubMed May TA, et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol. 2006;126(2):200–206.CrossRefPubMed
30.
go back to reference Novich M, Gillis L, Tauber AI. The laboratory test justified. An effective means to reduce routine laboratory testing. Am J Clin Pathol. 1985;84(6):756–759.PubMed Novich M, Gillis L, Tauber AI. The laboratory test justified. An effective means to reduce routine laboratory testing. Am J Clin Pathol. 1985;84(6):756–759.PubMed
Metadata
Title
The Effect of Charge Display on Cost of Care and Physician Practice Behaviors: A Systematic Review
Authors
Celine Goetz, MD
Stephen R. Rotman, MD
George Hartoularos
Tara F. Bishop, MD, MPH
Publication date
01-06-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3226-5

Other articles of this Issue 6/2015

Journal of General Internal Medicine 6/2015 Go to the issue

Clinical Practice: Exercises in Clinical Reasoning

Exercises In Clinical Reasoning

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.